Positive Impact of a Point-of-Care Molecular Influenza Test in the Emergency Department During the 2017-2018 Seasonal Influenza Epidemic
Positive Impact of a Point-of-Care Molecular Influenza Test in the Emergency Department During the 2017-2018 Seasonal Influenza Epidemic
复制标题
DOI：
10.1093/ofid/ofz312
复制
发表时间：
2019-07-01
影响因子：
4.2
通讯作者：
Thibaud, Eric
中科院分区：
文献类型：
--
作者：
Martinot, Martin;Greigert, Valentin;Thibaud, Eric
在 2017-2018 年流感流行期间，对床旁 Alere-i (n = 72) 和逆转录聚合酶链反应 (n = 106) 测试进行了比较。床旁护理组的患者服用奥司他韦的速度明显更快（9 小时 vs 23 小时），他们在急诊科花费的时间更少，抗生素使用率和住院率也更低。
During the 2017-2018 flu epidemic, the point-of-care Alere-i (n = 72) and reverse transcription polymerase chain reaction (n = 106) tests were compared. Patients in the point-of-care group were administered oseltamivir significantly more rapidly (9 hours vs 23 hours), they spent less time in the emergency department, and they had lower rates of antibiotic administration and hospitalization.